Philip Ron M
Director
Award
Calculated transaction value
$13.63K
1,109 shares @ $12.29
Traded
Sep 30, 2026
Filed
Oct 2, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Avalo Therapeutics
AVTX
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
56 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Philip Ron M Director | Oct 2, 2026 2-day lag | Award Sep 30, 2026 | $13.63K Filed shares x price | SEC Form 4 View filing | |
| Lind Kevin Robert Director | Oct 2, 2026 2-day lag | Award Sep 30, 2026 | $16.62K Filed shares x price | SEC Form 4 View filing | |
| Jain Rita Director | Oct 2, 2026 2-day lag | Award Sep 30, 2026 | $16.25K Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Sep 18, 2026 2-day lag | Exercise Sep 16, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Sep 18, 2026 2-day lag | Exercise Sep 16, 2026 | $122.45K Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Sep 18, 2026 2-day lag | Sale Sep 16, 2026 | $202.44K Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Sep 11, 2026 1-day lag | Sale Sep 10, 2026 | $179.46K Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Sep 11, 2026 1-day lag | Exercise Sep 10, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Sep 11, 2026 1-day lag | Exercise Sep 10, 2026 | $81.89K Filed shares x price | SEC Form 4 View filing | |
| Doyle Mittie Chief Medical Officer | Sep 1, 2026 4-day lag | Sale Aug 28, 2026 | $13.58K Filed shares x price | SEC Form 4 View filing | |
| Doyle Mittie Chief Medical Officer | Sep 1, 2026 4-day lag | Exercise Aug 28, 2026 | $5.46K Filed shares x price | SEC Form 4 View filing | |
| Doyle Mittie Chief Medical Officer | Sep 1, 2026 4-day lag | Exercise Aug 28, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Aug 19, 2026 1-day lag | Exercise Aug 18, 2026 | $306.59K Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Aug 19, 2026 1-day lag | Exercise Aug 18, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Aug 19, 2026 1-day lag | Sale Aug 18, 2026 | $622.32K Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Aug 19, 2026 2-day lag | Sale Aug 17, 2026 | $74.76K Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Aug 19, 2026 2-day lag | Exercise Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Aug 19, 2026 2-day lag | Exercise Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Aug 19, 2026 2-day lag | Exercise Aug 17, 2026 | $374.9K Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Aug 19, 2026 2-day lag | Sale Aug 17, 2026 | $753.33K Filed shares x price | SEC Form 4 View filing | |
| Sullivan Christopher Ryan Chief Financial Officer | Aug 19, 2026 2-day lag | Exercise Aug 17, 2026 | $28.41K Filed shares x price | SEC Form 4 View filing | |
| Doyle Mittie Chief Medical Officer | Aug 19, 2026 2-day lag | Exercise Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Doyle Mittie Chief Medical Officer | Aug 19, 2026 2-day lag | Exercise Aug 17, 2026 | $12.65K Filed shares x price | SEC Form 4 View filing | |
| Doyle Mittie Chief Medical Officer | Aug 19, 2026 2-day lag | Sale Aug 17, 2026 | $20K Filed shares x price | SEC Form 4 View filing | |
| Riley Jennifer Chief Strategy Officer | Aug 12, 2026 1-day lag | Sale Aug 11, 2026 | $52.01K Filed shares x price | SEC Form 4 View filing | |
| Doyle Mittie Chief Medical Officer | Aug 12, 2026 2-day lag | Sale Aug 10, 2026 | $13.58K Filed shares x price | SEC Form 4 View filing | |
| Doyle Mittie Chief Medical Officer | Aug 12, 2026 2-day lag | Exercise Aug 10, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Doyle Mittie Chief Medical Officer | Aug 12, 2026 2-day lag | Exercise Aug 10, 2026 | $5.46K Filed shares x price | SEC Form 4 View filing | |
| Doyle Mittie Chief Medical Officer | Jul 29, 2026 2-day lag | Sale Jul 27, 2026 | $20K Filed shares x price | SEC Form 4 View filing | |
| Doyle Mittie Chief Medical Officer | Jul 29, 2026 2-day lag | Exercise Jul 27, 2026 | $12.65K Filed shares x price | SEC Form 4 View filing |
Lind Kevin Robert
Director
Award
Calculated transaction value
$16.62K
1,352 shares @ $12.29
Traded
Sep 30, 2026
Filed
Oct 2, 2026
Jain Rita
Director
Award
Calculated transaction value
$16.25K
1,322 shares @ $12.29
Traded
Sep 30, 2026
Filed
Oct 2, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Exercise
Calculated transaction value
$0
12,394 shares @ $0
Traded
Sep 16, 2026
Filed
Sep 18, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Exercise
Calculated transaction value
$122.45K
12,394 shares @ $9.88
Traded
Sep 16, 2026
Filed
Sep 18, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Sale
Calculated transaction value
$202.44K
12,394 shares @ $16.33
Traded
Sep 16, 2026
Filed
Sep 18, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Sale
Calculated transaction value
$179.46K
10,185 shares @ $17.62
Traded
Sep 10, 2026
Filed
Sep 11, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Exercise
Calculated transaction value
$0
10,185 shares @ $0
Traded
Sep 10, 2026
Filed
Sep 11, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Exercise
Calculated transaction value
$81.89K
10,185 shares @ $8.04
Traded
Sep 10, 2026
Filed
Sep 11, 2026
Doyle Mittie
Chief Medical Officer
Sale
Calculated transaction value
$13.58K
679 shares @ $20
Traded
Aug 28, 2026
Filed
Sep 1, 2026
Doyle Mittie
Chief Medical Officer
Exercise
Calculated transaction value
$5.46K
679 shares @ $8.04
Traded
Aug 28, 2026
Filed
Sep 1, 2026
Doyle Mittie
Chief Medical Officer
Exercise
Calculated transaction value
$0
679 shares @ $0
Traded
Aug 28, 2026
Filed
Sep 1, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Exercise
Calculated transaction value
$306.59K
31,031 shares @ $9.88
Traded
Aug 18, 2026
Filed
Aug 19, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Exercise
Calculated transaction value
$0
31,031 shares @ $0
Traded
Aug 18, 2026
Filed
Aug 19, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Sale
Calculated transaction value
$622.32K
31,031 shares @ $20.05
Traded
Aug 18, 2026
Filed
Aug 19, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Sale
Calculated transaction value
$74.76K
3,749 shares @ $19.94
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Exercise
Calculated transaction value
$0
2,876 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Exercise
Calculated transaction value
$0
37,945 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Exercise
Calculated transaction value
$374.9K
37,945 shares @ $9.88
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Sale
Calculated transaction value
$753.33K
37,945 shares @ $19.85
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Sullivan Christopher Ryan
Chief Financial Officer
Exercise
Calculated transaction value
$28.41K
2,876 shares @ $9.88
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Doyle Mittie
Chief Medical Officer
Exercise
Calculated transaction value
$0
1,000 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Doyle Mittie
Chief Medical Officer
Exercise
Calculated transaction value
$12.65K
1,000 shares @ $12.65
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Doyle Mittie
Chief Medical Officer
Sale
Calculated transaction value
$20K
1,000 shares @ $20
Traded
Aug 17, 2026
Filed
Aug 19, 2026
Riley Jennifer
Chief Strategy Officer
Sale
Calculated transaction value
$52.01K
2,655 shares @ $19.59
Traded
Aug 11, 2026
Filed
Aug 12, 2026
Doyle Mittie
Chief Medical Officer
Sale
Calculated transaction value
$13.58K
679 shares @ $20
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Doyle Mittie
Chief Medical Officer
Exercise
Calculated transaction value
$0
679 shares @ $0
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Doyle Mittie
Chief Medical Officer
Exercise
Calculated transaction value
$5.46K
679 shares @ $8.04
Traded
Aug 10, 2026
Filed
Aug 12, 2026
Doyle Mittie
Chief Medical Officer
Sale
Calculated transaction value
$20K
1,000 shares @ $20
Traded
Jul 27, 2026
Filed
Jul 29, 2026
Doyle Mittie
Chief Medical Officer
Exercise
Calculated transaction value
$12.65K
1,000 shares @ $12.65
Traded
Jul 27, 2026
Filed
Jul 29, 2026